Literature DB >> 11398635

Chromoblastomycosis: clinical and mycologic experience of 51 cases.

A Bonifaz1, E Carrasco-Gerard, A Saúl.   

Abstract

This is a study of 51 cases of chromoblastomycosis detected in a 17-year period, all of which were clinically and mycologically proven by direct examinations, cultures and biopsies. The therapeutic results of the various treatments used are reported. Most cases were males (36 of 51; 70%), the mean age was 35 years and farmers predominated (74%); the most frequent lesions were in the lower limbs (54%). Major clinical presentations were nodular (41%) and verrucous (26%). The principal aetiologic agent isolated was Fonsecaea pedrosoi (90%). Overall results of the various treatments were as follows: 31% were cured, 57% improved and 12% failed. The best results were obtained with cryosurgery for small lesions, with itraconazole for large ones, and in some cases the combination of both treatments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11398635     DOI: 10.1046/j.1439-0507.2001.00613.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  43 in total

1.  Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2011-03-26

Review 2.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.

Authors:  O Carolina Rojas; Gloria M González; María Moreno-Treviño; Julio Salas-Alanis
Journal:  Mycopathologia       Date:  2014-10-25       Impact factor: 2.574

4.  Subcutaneous fungal infections.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

5.  Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.

Authors:  Enrique Calvo; F Javier Pastor; Emilio Mayayo; Pilar Hernández; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

Review 6.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 7.  CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE.

Authors:  Flavio Queiroz-Telles
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

8.  In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.

Authors:  Mohammad J Najafzadeh; Hamid Badali; Maria Teresa Illnait-Zaragozi; G Sybren De Hoog; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Rapid identification of the genus fonsecaea by PCR with specific oligonucleotide primers.

Authors:  Paride Abliz; Kazutaka Fukushima; Kayoko Takizawa; Norikazu Nieda; Makoto Miyaji; Kazuko Nishimura
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba.

Authors:  Hamid Badali; Maydelin Fernández-González; Bita Mousavi; Maria Teresa Illnait-Zaragozi; Juan Carlos González-Rodríguez; G Sybren de Hoog; Jacques F Meis
Journal:  Mycopathologia       Date:  2013-03-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.